ArticleEuropean journal of medical research2026

PD-L1 status on circulating tumor cells: a promising predictor in advanced lung cancer with PD-1/PD-L1 immunotherapies.

Xiaoying Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.